Recent evidence has suggested that the diabetic environment (particularly type 2 diabetes) may provide the appropriate triggers to activate inflammasomes, specifically the NOD-like receptor 3 (NLRP3) inflammasome [6, 7]. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.